Hasil Pencarian - Toru Kumagai

Perbaiki Hasil
  1. 1
    Afatinib-induced severe esophagitis in a lung cancer patient with an activated epidermal growth factor receptor mutation: A case report

    Afatinib-induced severe esophagitis in a lung cancer patient with an activated epidermal growth factor receptor mutation: A case report oleh Takako Inoue, Madoka Kimura, Motohiro Tamiya, Kazumi Nishino, Toru Kumagai, Fumio Imamura

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Capmatinib successfully overcomes tepotinib‐induced intolerable peripheral edema

    Capmatinib successfully overcomes tepotinib‐induced intolerable peripheral edema oleh Kei Kunimasa, Takahisa Kawamura, Motohiro Tamiya, Takako Inoue, Hanako Kuhara, Kazumi Nishino, Toru Kumagai

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Oligomer-Targeting Prevention of Neurodegenerative Dementia by Intranasal Rifampicin and Resveratrol Combination – A Preclinical Study in Model Mice

    Oligomer-Targeting Prevention of Neurodegenerative Dementia by Intranasal Rifampicin and Resveratrol Combination – A Preclinical Study in Model Mice oleh Tomohiro Umeda, Ayumi Sakai, Keiko Shigemori, Ayumi Yokota, Toru Kumagai, Takami Tomiyama, Takami Tomiyama

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Favorable response to pembrolizumab after durvalumab failure in a stage III sarcomatoid carcinoma of the lung: a case report

    Favorable response to pembrolizumab after durvalumab failure in a stage III sarcomatoid carcinoma of the lung: a case report oleh Kazumi Nishino, Kei Kunimasa, Madoka Kimura, Takako Inoue, Motohiro Tamiya, Hanako Kuhara, Toru Kumagai

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Pneumothorax triggered by the combination of gefitinib and amrubicin and treated with endobronchial silicone spigots

    Pneumothorax triggered by the combination of gefitinib and amrubicin and treated with endobronchial silicone spigots oleh Fumio Imamura, Norio Okamoto, Takako Inoue, Junji Uchida, Kazumi Nishino, Madoka Kimura, Toru Kumagai, Jiro Okami

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Quantitative identification of mutant alleles derived from lung cancer in plasma cell-free DNA via anomaly detection using deep sequencing data.

    Quantitative identification of mutant alleles derived from lung cancer in plasma cell-free DNA via anomaly detection using deep sequencing data. oleh Yoji Kukita, Junji Uchida, Shigeyuki Oba, Kazumi Nishino, Toru Kumagai, Kazuya Taniguchi, Takako Okuyama, Fumio Imamura, Kikuya Kato

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    The ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR-TKI-refractory NSCLC

    The ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR-TKI-refractory NSCLC oleh Motohiro Tamiya, Akihiro Tamiya, Norio Okamoto, Yoshihiko Taniguchi, Kazumi Nishino, Shinji Atagi, Tomonori Hirashima, Fumio Imamura, Toru Kumagai, Hidekazu Suzuki

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Infectious pericarditis caused by Gemella sanguinis induced by Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA): A case report

    Infectious pericarditis caused by Gemella sanguinis induced by Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA): A case report oleh Takako Inoue, Tatsuya Nishikawa, Kei Kunimasa, Motohiro Tamiya, Hanako Kuhara, Kazumi Nishino, Mamoru Fujiwara, Masashi Fujita, Fumio Imamura, Toru Kumagai

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Fragment size and dynamics of EGFR-mutated tumor-derived DNA provide prognostic information regarding EGFR-TKI efficacy in patients with EGFR-mutated NSCLC

    Fragment size and dynamics of EGFR-mutated tumor-derived DNA provide prognostic information regarding EGFR-TKI efficacy in patients with EGFR-mutated NSCLC oleh Kei Kunimasa, Kazumi Nishino, Yoshiharu Sato, Masahide Mori, Shoichi Ihara, Hidekazu Suzuki, Izumi Nagatomo, Toru Kumagai, Toshitaka Morishima, Fumio Imamura

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Overexpression of PIAS3 Suppresses Cell Growth, Restores the Drug Sensitivity of Human Lung Cancer Cells in Association with PI3-K/Akt Inactivation

    Overexpression of PIAS3 Suppresses Cell Growth, Restores the Drug Sensitivity of Human Lung Cancer Cells in Association with PI3-K/Akt Inactivation oleh Yoshitaka Ogata, Tadashi Osaki, Tetsuji Naka, Kota Iwahori, Mitsugi Furukawa, Izumi Nagatomo, Takashi Kijima, Toru Kumagai, Mitsuhiro Yoshida, Isao Tachibana, Ichiro Kawase

    Diterbitkan 2006-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer

    A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer oleh Yoshihiro Hattori, Yuko Kono, Shoichi Itoh, Takako Inoue, Yoshiko Urata, Yoshitaka Kawa, Rie Tohnai, Toru Kumagai, Kazumi Nishino, Ryuji Uozumi, Satoshi Morita, Shunichi Negoro, Fumio Imamura, Miyako Satouchi

    Diterbitkan 2020-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Comparison of sampling methods for next generation sequencing for patients with lung cancer

    Comparison of sampling methods for next generation sequencing for patients with lung cancer oleh Kei Kunimasa, Shingo Matsumoto, Kazumi Nishino, Keiichiro Honma, Noboru Maeda, Hanako Kuhara, Motohiro Tamiya, Takako Inoue, Takahisa Kawamura, Toru Kimura, Tomohiro Maniwa, Jiro Okami, Koichi Goto, Toru Kumagai

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Cytokine Release Syndrome and Immune-Related Pneumonitis Associated With Tumor Progression in a Pulmonary Pleomorphic Carcinoma Treated With Nivolumab Plus Ipilimumab Treatment: A Case Report

    Cytokine Release Syndrome and Immune-Related Pneumonitis Associated With Tumor Progression in a Pulmonary Pleomorphic Carcinoma Treated With Nivolumab Plus Ipilimumab Treatment: A... oleh Kei Kunimasa, MD, PhD, Takako Inoue, MD, Katsunori Matsueda, MD, Takahisa Kawamura, MD, PhD, Motohiro Tamiya, MD, Kazumi Nishino, MD, PhD, Toru Kumagai, MD, PhD

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial.

    Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial. oleh Motohiro Tamiya, Akihiro Tamiya, Takako Inoue, Madoka Kimura, Kei Kunimasa, Kenji Nakahama, Yoshihiko Taniguchi, Takayuki Shiroyama, Shun-Ichi Isa, Kazumi Nishino, Toru Kumagai, Hidekazu Suzuki, Tomonori Hirashima, Shinji Atagi, Fumio Imamura

    Diterbitkan 2018-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Efficacy and safety of mycophenolate mofetil in treating immune‐related hepatitis induced by immune checkpoint inhibitor use: A retrospective study

    Efficacy and safety of mycophenolate mofetil in treating immune‐related hepatitis induced by immune checkpoint inhibitor use: A retrospective study oleh Yukio Kadokawa, Satoko Inoue, Akitoshi Tatsumi, Mayako Uchida, Keiko Fujita, Mari Takagi, Takako Inoue, Shuichi Ohe, Yasutomo Nakai, Tomoyuki Otsuka, Yutaro Abe, Tasuku Nakabori, Taiki Isei, Toru Kumagai, Kazuo Nishimura, Kazuyoshi Ohkawa

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    TP53 Loss of Heterozygosity Induces De Novo SCLC Formation in EGFR-Mutated Lung Adenocarcinoma: A Case Report

    TP53 Loss of Heterozygosity Induces De Novo SCLC Formation in EGFR-Mutated Lung Adenocarcinoma: A Case Report oleh Kei Kunimasa, MD, PhD, Yosuke Hirotsu, PhD, Kenji Amemiya, MSH, Harumi Nakamura, MD, PhD, Kazumi Nishino, MD, PhD, Keiichiro Honma, MD, PhD, Jiro Okami, MD, PhD, Masao Omata, MD, PhD, Toru Kumagai, MD, PhD

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Genome analysis of peeling archival cytology samples detects driver mutations in lung cancer

    Genome analysis of peeling archival cytology samples detects driver mutations in lung cancer oleh Kei Kunimasa, Yosuke Hirotsu, Kenji Amemiya, Yuki Nagakubo, Taichiro Goto, Yoshihiro Miyashita, Yumiko Kakizaki, Toshiharu Tsutsui, Sotaro Otake, Hiroaki Kobayashi, Rumi Higuchi, Kie Inomata, Takashi Kumagai, Hitoshi Mochizuki, Harumi Nakamura, Shin‐ichi Nakatsuka, Kazumi Nishino, Fumio Imamura, Toru Kumagai, Toshio Oyama, Masao Omata

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study

    Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer... oleh Kazutaka Hosoya, Daichi Fujimoto, Takeshi Morimoto, Toru Kumagai, Akihiro Tamiya, Yoshihiko Taniguchi, Toshihide Yokoyama, Tadashi Ishida, Hirotaka Matsumoto, Katsuya Hirano, Ryota Kominami, Keisuke Tomii, Hidekazu Suzuki, Tomonori Hirashima, Satoshi Tanaka, Junji Uchida, Mitsunori Morita, Masaki Kanazu, Masahide Mori, Kenji Nagata, Ikue Fukuda, Motohiro Tamiya

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Manual route modification using an oblique method following automatic virtual bronchoscopic navigation

    Manual route modification using an oblique method following automatic virtual bronchoscopic navigation oleh Takako Inoue, MD, Takahisa Kawamura, MD, PhD, Kei Kunimasa, MD, PhD, Motohiro Tamiya, MD, Hanako Kuhara, MD, PhD, Kazumi Nishino, MD, PhD, Satomi Odani, MPH, Fumio Imamura, MD, PhD, Toru Kumagai, MD, PhD, Kotaro Miyake, MD, PhD, Mihai Dorin Vartolomei.

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    First-Line Lorlatinib Versus Crizotinib in ALK-Positive NSCLC: Japanese Subgroup Analysis of CROWN

    First-Line Lorlatinib Versus Crizotinib in ALK-Positive NSCLC: Japanese Subgroup Analysis of CROWN oleh Hidetoshi Hayashi, MD, PhD, Shunsuke Teraoka, MD, Yasushi Goto, MD, PhD, Toru Kumagai, MD, PhD, Makoto Nishio, MD, PhD, Shunichi Sugawara, MD, PhD, Satoshi Oizumi, MD, PhD, Masakazu Matsumura, MS, Masayuki Okura, PhD, Gerson Peltz, MD, MPH, Terufumi Kato, MD

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: